معرفی
Markus Herberg Hovd is a Senior Lecturer at the Section for Pharmacology and Pharmaceutical Biosciences, University of Oslo. He holds academic affiliations with the Neurosurgical Department and the KG Jebsen Centre for Brain Fluid Research. His research focuses on pharmacokinetic variability, population-based pharmacokinetic modeling, and clinical pharmacometrics with applications in personalized medicine. He teaches courses including FARM5150 (Applied Pharmacokinetics) and contributes to academic committees such as the Department Board and Teaching Committee.
Dr. Hovd earned a Master of Pharmacy (2019) and a PhD (2024) from the University of Oslo, both in Pharmacy. His doctoral work addressed clinical pharmacometrics and non-parametric techniques in pharmacokinetic studies.
His research interests span pharmacokinetic modeling (popPK/PBPK), in vitro-in vivo extrapolation (IVIVE), and drug dosing optimization in special populations such as kidney transplant recipients and patients undergoing weight loss interventions. Key areas include drug metabolism variability, CSF clearance mechanisms, and vaccine efficacy in immunosuppressed patients.
Recent publications highlight studies on drug pharmacokinetics in renal transplant recipients, obesity-related drug metabolism changes, and glymphatic system dynamics in neurological disorders. His work integrates clinical trials with advanced computational models to improve therapeutic drug monitoring and personalized treatment strategies.
Labs/Teams: Active member of the Kidney Transplantation research group, Pharmacokinetics group, and the KG Jebsen Centre for Brain Fluid Research.
